Tuesday, 11 September 2012

Vitetal Elixir





Dosage Form: oral liquid
Vitetal Elixir - Orange

CIV

Vitetal Elixir Prescribing Info


Rx Only



Description


Each Vitetal 5 mL (teaspoonful) of elixir contains:












Phenobarbital, USP16.2 mg
Hyoscyamine Sulfate, USP0.1037 mg
Atropine Sulfate, USP0.0194 mg
Scopolamine Hydrobromide, USP0.0065 mg
Alcohol23%

INACTIVE INGREDIENTS


Ethyl Alcohol, Glycerin, Purified Water, Saccharin Sodium, Sorbitol Solution, Natural and Artificial Orange Flavor, FD & C Red #40.



Vitetal Elixir - Clinical Pharmacology


This drug combination provides natural belladonna alkaloids in a specific, fixed ratio combined with phenobarbital to provide peripheral anticholinergic/antispasmodic action and mild sedation.







INDICATIONS
Based on a review of this drug by the National Academy of Sciences - National Research Council and/or other information, FDA has classified the following indications as "possibly" effective:

 
For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.

 
May also be useful as adjunctive therapy in the treatment of duodenal ulcer. IT HAS NOT BEEN SHOWN CONCLUSIVELY WHETHER ANTICHOLINERGIC/ANTISPASMODIC DRUGS AID IN THE HEALING OF A DUODENAL ULCER, DECREASE THE RATE OF RECURRENCES OR PREVENT COMPLICATIONS.

Contraindications


Glaucoma, obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); paralytic ileus, intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis especially if complicated by toxic megacolon; myasthenia gravis; hiatal hernia associated with reflux esophagitis.


Vitetal Elixir is contraindicated in patients with known hypersensitivity to any of the ingredients. Phenobarbital is contraindicated in acute intermittent porphyria and in those patients in whom phenobarbital produces restlessness and/or excitement.



Warnings


In the presence of a high environmental temperature, heat prostration can occur with belladonna alkaloids (fever and heatstroke due to decreased sweating).


Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy. In this instance, treatment with this drug would be inappropriate and possibly harmful.


Vitetal Elixir may produce drowsiness or blurred vision. The patient should be warned, should these occur, not to engage in activities requiring mental alertness, such as operating a motor vehicle or other machinery, and not to perform hazardous work.


Phenobarbital may decrease the effect of anticoagulants, and necessitate larger doses of the anticoagulant for optimal effect. When the phenobarbital is discontinued, the dose of the anticoagulant may have to be decreased.


Phenobarbital may be habit forming and should not be administered to individuals known to be addiction prone or to those with a history of physical and/or psychological dependence upon drugs.


Since barbiturates are metabolized in the liver, they should be used with caution and initial doses should be small in patients with hepatic dysfunction.



Precautions



GENERAL


Use with caution in patients with: autonomic neuropathy, hepatic or renal disease, hyperthyroidism, coronary heart disease, congestive heart failure, cardiac arrhythmias, tachycardia, and hypertension.


Belladonna alkaloids may produce a delay in gastric emptying (antral stasis) which would complicate the management of gastric ulcer.


Do not rely on the use of the drug in the presence of complication of biliary tract disease. Theoretically, with overdosage, a curare-like action may occur.



CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY


Long-term studies in animals have not been performed to evaluate carcinogenic potential.



PREGNANCY


PREGNANCY CATEGORY C

Animal reproduction studies have not been conducted with Vitetal Elixir. It is not known whether Vitetal Elixir can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Vitetal Elixir should be given to a pregnant woman only if clearly needed.



NURSING MOTHERS


It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Vitetal Elixir is administered to a nursing woman.



Adverse Reactions


Adverse reactions may include xerostomia; urinary hesitancy and retention; blurred vision; tachycardia; palpitation; mydriasis; cycloplegia; increased ocular tension; loss of taste sense; headache; nervousness; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; impotence; suppression of lactation; constipation; bloated feeling; musculoskeletal pain; severe allergic reaction or drug idiosyncrasies, including anaphylaxis, urticaria and other dermal manifestations; and decreased sweating. Elderly patients may react with symptoms of excitement, agitation, drowsiness, and other untoward manifestations to even small doses of the drug. Phenobarbital may produce excitement in some patients, rather than a sedative effect. In patients habituated to barbiturates, abrupt withdrawal may produce delirium or convulsions.



Overdosage


The signs and symptoms of overdose are headache, nausea, vomiting, blurred vision, dilated pupils, hot and dry skin, dizziness, dryness of the mouth, difficulty in swallowing, and CNS stimulation. Treatment should consist of gastric lavage, emetics, and activated charcoal. If indicated, parenteral cholinergic agents such as physostigmine or bethanechol chloride, should be used.



Vitetal Elixir Dosage and Administration


The dosage of Vitetal Elixir should be adjusted to the needs of the individual patient to assure symptomatic control with a minimum of adverse effects.



Vitetal Elixir. Adults


One or two teaspoonfuls of elixir three or four times a day according to conditions and severity of symptoms.



Pediatric patients


may be dosed every 4 to 6 hours.

























Starting dosage
Body weightq4hq6h
10 lb. (4.5 kg)0.5 mL0.75 mL
20 lb. (9.1 kg)1.0 mL1.5 mL
30 lb. (13.6 kg)1.5 mL2.0 mL
50 lb. (22.7 kg)1/2 tsp3/4 tsp
75 lb. (34 kg)3/4 tsp1 tsp
100 lb. (45.4 kg)1 tsp1 1/2 tsp

How is Vitetal Elixir Supplied


Vitetal Elixir red colored, orange flavored liquid.


 

4 fl oz (118 mL) bottles    NDC 16571-320-04.

 

1 Pint (473 mL) bottles    NDC 16571-320-16.


AVOID FREEZING


Store Vitetal Elixir at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].


Protect from light and moisture.


Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Use safety closures when dispensing this product unless otherwise directed by a physician or requested by purchaser.



Distributed by:

PACK PHARMACEUTICALS, LLC

Buffalo Grove, IL 60089


Manufactured by:

Bio-Pharm, Inc.

Levittown, PA 19057


TO REPORT ADVERSE DRUG EVENTS CALL: (866) 562-4597


REV 09/2011



PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label


NDC 16571-320-16

TAMPER EVIDENT


Vitetal

Elixir CIV


Orange Flavored


Each 5 mL (1 teaspoonful) contains:

Phenobarbital, USP               16.2 mg

Hyoscyamine

Sulfate, USP                      0.1037 mg

Atropine

Sulfate, USP                      0.0194 mg

Scopolamine

Hydrobromide, USP          0.0065 mg

Alcohol                                      23%


DO NOT USE IF TAMPER-

EVIDENT SEAL UNDER CAP IS

BROKEN OR MISSING.


Bulk Container-

Not For Household Use


Distributed by:

PACK PHARMACEUTICALS, LLC

Buffalo Grove, IL 60089


Manufactured by:

Bio-Pharm, Inc.

Levittown, PA 19057


PACK

PHARMACEUTICALS, LLC


Rx Only


NET: 1 PINT (473 mL)










VITETAL 
phenobarbital, hyoscyamine sulfate, atropine sulfate, and scopolamine hydrobromide  liquid










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)16571-320
Route of AdministrationORALDEA ScheduleCIV    

















Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Phenobarbital (Phenobarbital)Phenobarbital16.2 mg  in 5 mL
Hyoscyamine Sulfate (Hyoscyamine)Hyoscyamine Sulfate0.1037 mg  in 5 mL
Atropine Sulfate (Atropine)Atropine Sulfate0.0194 mg  in 5 mL
Scopolamine Hydrobromide (Scopolamine)Scopolamine Hydrobromide0.0065 mg  in 5 mL


















Inactive Ingredients
Ingredient NameStrength
Glycerin 
alcohol 
Sorbitol 
Saccharin Sodium 
Orange 
FD&C Red no. 40 
Water 


















Product Characteristics
ColorORANGEScore    
ShapeSize
FlavorORANGEImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
116571-320-16473 mL In 1 BOTTLENone
216571-320-04120 mL In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER10/01/2011


Labeler - Pack Pharmaceuticals LLC (614823875)
Revised: 09/2011Pack Pharmaceuticals LLC

More Vitetal Elixir resources


  • Vitetal Elixir Use in Pregnancy & Breastfeeding
  • Drug Images
  • Vitetal Elixir Drug Interactions
  • Vitetal Elixir Support Group
  • 11 Reviews for Vitetal - Add your own review/rating


Compare Vitetal Elixir with other medications


  • Duodenal Ulcer
  • Enterocolitis
  • Irritable Bowel Syndrome

No comments:

Post a Comment